Your search returned 2 results.

Results
	1.	The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin. [electronic resource] by Ordóñez, José Luis Amaral, Ana Teresa Carcaboso, Angel M Herrero-Martín, David del Carmen García-Macías, María Sevillano, Vicky Alonso, Diego Pascual-Pasto, Guillem San-Segundo, Laura Vila-Ubach, Monica Rodrigues, Telmo Fraile, Susana Teodosio, Cristina Mayo-Iscar, Agustín Aracil, Miguel Galmarini, Carlos María Tirado, Oscar M Mora, Jaume de Álava, Enrique Producer: 20160608 In: Oncotarget vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin. [electronic resource] by Ordóñez, José Luis Amaral, Ana Teresa Carcaboso, Angel M Herrero-Martín, David García-Macías, María Del Carmen Sevillano, Vicky Alonso, Diego Pascual-Pasto, Guillem San-Segundo, Laura Vila-Ubach, Monica Rodrigues, Telmo Fraile, Susana Teodosio, Cristina Mayo-Iscar, Agustín Aracil, Miguel Galmarini, Carlos María Tirado, Oscar M Mora, Jaume de Álava, Enrique Publication details: Oncotarget 06 2017 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search